G
Genedrive PLC
LSE:GDR
Genedrive PLC
LSE:GDR
Price:
2.25 GBX
-35.71%
Market Closed
Updated:
May 13, 2024
Genedrive PLC
Research & Development
|
Genedrive PLC
Research & Development Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Genedrive PLC
LSE:GDR
|
Research & Development
-£3.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-7%
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Research & Development
-£103.8m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Genedrive PLC's Research & Development?
Research & Development
-3.8m
GBP
-3.8m
GBP
Based on the financial report for Dec 31, 2023, Genedrive PLC's Research & Development amounts to -3.8m GBP.
What is Genedrive PLC's Research & Development growth rate?
Research & Development CAGR 10Y
-7%
-7%
Over the last year, the Research & Development growth was 3%. The average annual Research & Development growth rates for Genedrive PLC have been 7% over the past three years , 13% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet
